↓ Skip to main content

Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease
Published in
Orphanet Journal of Rare Diseases, March 2021
DOI 10.1186/s13023-021-01781-w
Pubmed ID
Authors

Thamal Darshana, David Rees, Anuja Premawardhena

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 11%
Student > Master 5 9%
Lecturer 3 5%
Student > Postgraduate 3 5%
Unspecified 2 4%
Other 5 9%
Unknown 33 58%
Readers by discipline Count As %
Medicine and Dentistry 10 18%
Biochemistry, Genetics and Molecular Biology 5 9%
Nursing and Health Professions 3 5%
Unspecified 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 4 7%
Unknown 32 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2021.
All research outputs
#5,861,445
of 23,308,124 outputs
Outputs from Orphanet Journal of Rare Diseases
#740
of 2,673 outputs
Outputs of similar age
#128,490
of 429,197 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#29
of 85 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 2,673 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,197 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.